Cite
HARVARD Citation
Sendur, S. et al. (2022). Specific FSTL1 polymorphism may determine the risk of cardiomyopathy in patients with acromegaly. Acta cardiologica. 77 (4), pp. 350-359. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sendur, S. et al. (2022). Specific FSTL1 polymorphism may determine the risk of cardiomyopathy in patients with acromegaly. Acta cardiologica. 77 (4), pp. 350-359. [Online].